ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro total assets
Total assets on the balance sheet at the end of each period.
ClearPoint Neuro's total assets was $112.73M at Sep 30, 2026. For fiscal 2025 it was $97.75M, up 149.4% from the year before. Over ten years it grew 25.7% a year on average. The highest annual figure on record is $97.75M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.75M | +149.4% |
| FY2024 | Dec 31, 2024 | $39.19M | -8.1% |
| FY2023 | Dec 31, 2023 | $42.66M | -23.1% |
| FY2022 | Dec 31, 2022 | $55.49M | -15.4% |
| FY2021 | Dec 31, 2021 | $65.58M | +122.2% |
| FY2020 | Dec 31, 2020 | $29.52M | +147.5% |
| FY2019 | Dec 31, 2019 | $11.93M | +51.8% |
| FY2018 | Dec 31, 2018 | $7.86M | -43.5% |
| FY2017 | Dec 31, 2017 | $13.90M | +87.8% |
| FY2016 | Dec 31, 2016 | $7.40M | -25.5% |
| FY2015 | Dec 31, 2015 | $9.94M | -25.8% |
| FY2014 | Dec 31, 2014 | $13.39M | +70.0% |
| FY2013 | Dec 31, 2013 | $7.87M | +41.8% |
| FY2012 | Dec 31, 2012 | $5.55M | +83.2% |
| FY2011 | Dec 31, 2011 | $3.03M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $112.73M | +86.8% |
| Q2 FY2026 | Jun 30, 2026 | $86.74M | +38.0% |
| Q1 FY2026 | Mar 31, 2026 | $93.42M | +210.7% |
| Q4 FY2025 | Dec 31, 2025 | $97.75M | +149.4% |
| Q3 FY2025 | Sep 30, 2025 | $60.36M | +50.2% |
| Q2 FY2025 | Jun 30, 2025 | $62.87M | +19.6% |
| Q1 FY2025 | Mar 31, 2025 | $30.07M | -43.9% |
| Q4 FY2024 | Dec 31, 2024 | $39.19M | -8.1% |
| Q3 FY2024 | Sep 30, 2024 | $40.19M | -8.3% |
| Q2 FY2024 | Jun 30, 2024 | $52.57M | +10.4% |
| Q1 FY2024 | Mar 31, 2024 | $53.64M | +6.7% |
| Q4 FY2023 | Dec 31, 2023 | $42.66M | -23.1% |
| Q3 FY2023 | Sep 30, 2023 | $43.84M | -24.1% |
| Q2 FY2023 | Jun 30, 2023 | $47.64M | -20.9% |
| Q1 FY2023 | Mar 31, 2023 | $50.25M | -18.7% |
| Q4 FY2022 | Dec 31, 2022 | $55.49M | -15.4% |
| Q3 FY2022 | Sep 30, 2022 | $57.74M | -16.0% |
| Q2 FY2022 | Jun 30, 2022 | $60.24M | -16.7% |
| Q1 FY2022 | Mar 31, 2022 | $61.77M | -16.8% |
| Q4 FY2021 | Dec 31, 2021 | $65.58M | +122.2% |
| Q3 FY2021 | Sep 30, 2021 | $68.70M | +214.5% |
| Q2 FY2021 | Jun 30, 2021 | $72.33M | +214.0% |
| Q1 FY2021 | Mar 31, 2021 | $74.26M | +214.9% |
| Q4 FY2020 | Dec 31, 2020 | $29.52M | +147.5% |
| Q3 FY2020 | Sep 30, 2020 | $21.85M | +63.2% |
| Q2 FY2020 | Jun 30, 2020 | $23.03M | +73.6% |
| Q1 FY2020 | Mar 31, 2020 | $23.59M | +209.3% |
| Q4 FY2019 | Dec 31, 2019 | $11.93M | +51.8% |
| Q3 FY2019 | Sep 30, 2019 | $13.39M | +54.3% |
| Q2 FY2019 | Jun 30, 2019 | $13.27M | +14.5% |
| Q1 FY2019 | Mar 31, 2019 | $7.63M | -38.2% |
| Q4 FY2018 | Dec 31, 2018 | $7.86M | -43.5% |
| Q3 FY2018 | Sep 30, 2018 | $8.68M | -43.9% |
| Q2 FY2018 | Jun 30, 2018 | $11.59M | -31.2% |
| Q1 FY2018 | Mar 31, 2018 | $12.35M | +99.5% |
| Q4 FY2017 | Dec 31, 2017 | $13.90M | +87.8% |
| Q3 FY2017 | Sep 30, 2017 | $15.46M | – |
| Q2 FY2017 | Jun 30, 2017 | $16.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.19M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.40M | – |
See a number that looks wrong?